Skip to main content
Contact Us
Subscribe
E-Edition
64°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Virpax Pharmaceuticals, Inc. - Common Stock
(NQ:
VRPX
)
0.1780
-0.0040 (-2.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Virpax Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
36 Stocks Moving In Wednesday's Mid-Day Session
August 25, 2021
Gainers Locust Walk Acquisition Corp. (NASDAQ: LWAC) shares jumped 188% to $25.34 after the company announced stockholders approved a business combination with eFFECTOR...
Via
Benzinga
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
August 22, 2021
Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues,...
Via
Benzinga
Exposures
Product Safety
22 Stocks Moving in Friday's Pre-Market Session
August 20, 2021
Gainers GeoVax Labs, Inc.. (NASDAQ: GOVX) shares rose 72.1% to $7.40 in pre-market trading after the company announced it presented COVID-19 vaccine data at the European Society...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
August 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
58 Biggest Movers From Yesterday
August 20, 2021
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
August 19, 2021
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 141% to $1.7950 after dropping 12% on Wednesday. Sonnet BioTherapeutics recently reported its financial...
Via
Benzinga
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
August 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
21 Stocks Moving in Thursday's Pre-Market Session
August 19, 2021
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares rose 86.5% to $1.39 in pre-market trading after dropping 12% on Wednesday. Sonnet BioTherapeutics recently...
Via
Benzinga
46 Biggest Movers From Yesterday
August 19, 2021
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday. SGOCO Group, Ltd. (NASDAQ: SGOC) surged 67...
Via
Benzinga
VRPX Stock: What Investors Are Saying About Virpax Pharma as Shares Continue to Fly
August 18, 2021
Shares of VRPX stock continue to blow up on Wednesday after Virpax Pharmaceuticals' massive business announcement on Tuesday.
Via
InvestorPlace
Exposures
Product Safety
Mid-Afternoon Market Update: Crude Oil Down 1.5%; Tuya Shares Plummet
August 18, 2021
Toward the end of trading Wednesday, the Dow traded down 0.27% to 35,249.25 while the NASDAQ rose 0.06% to 14,664.67. The S&P also fell, dropping 0.21% to 4,438.73. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Mid-Day Market Update: Alcon Rises Following Q2 Results; NexPoint Real Estate Finance Shares Slide
August 18, 2021
Midway through trading Wednesday, the Dow traded down 0.12% to 35,299.82 while the NASDAQ fell 0.01% to 14,654.93. The S&P also fell, dropping 0.10% to 4,443.63. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
34 Stocks Moving In Wednesday's Mid-Day Session
August 18, 2021
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday. Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 58% to $...
Via
Benzinga
Stocks That Hit 52-Week Highs On Wednesday
August 18, 2021
Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs. Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market cap basis to set a new...
Via
Benzinga
Mid-Morning Market Update: Markets Mixed; Target Reports Upbeat Profit
August 18, 2021
Following the market opening Wednesday, the Dow traded down 0.12% to 35,300.85 while the NASDAQ rose 0.03% to 14,660.26. The S&P also fell, dropping 0.04% to 4,446.09. The U.S...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
22 Stocks Moving in Wednesday's Pre-Market Session
August 18, 2021
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares rose 50.6% to $23.12 in pre-market trading. Virpax Pharmaceuticals shares jumped 265% on Tuesday after the company...
Via
Benzinga
66 Biggest Movers From Yesterday
August 18, 2021
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND...
Via
Benzinga
Why Virpax Pharmaceuticals Shares Are Soaring Today
August 17, 2021
Virpax Pharmaceuticals Inc (NASDAQ: VRPX) is surging higher Tuesday after the company announced that it received a written pre-investigational new drug response from the...
Via
Benzinga
Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; Virpax Pharmaceuticals Shares Spike Higher
August 17, 2021
Toward the end of trading Tuesday, the Dow traded down 1.18% to 35,204.03 while the NASDAQ fell 1.24% to 14,610.77. The S&P also fell, dropping 1.06% to 4,432.01. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
VRPX Stock: 6 Things for Virpax Pharma Investors to Know as Shares Rocket Over 250%
August 17, 2021
Virpax Pharma (VRPX) stock is rocketing higher on Tuesday after getting a response from the FDA concerning an anti-viral barrier product.
Via
InvestorPlace
Exposures
Product Safety
Mid-Day Market Update: monday.com Jumps Following Strong Q2 Results; Kubient Shares Plunge
August 17, 2021
Midway through trading Tuesday, the Dow traded down 0.81% to 35,336.88 while the NASDAQ fell 0.89% to 14,661.86. The S&P also fell, dropping 0.65% to 4,450.54. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
48 Stocks Moving In Tuesday's Mid-Day Session
August 17, 2021
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA...
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower; Walmart Profit Tops Estimates
August 17, 2021
Following the market opening Tuesday, the Dow traded down 0.67% to 35,385.44 while the NASDAQ fell 0.79% to 14,676.74. The S&P also fell, dropping 0.54% to 4,455.32. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stocks That Hit 52-Week Highs On Tuesday
August 17, 2021
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs. Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market cap to set a new 52-week...
Via
Benzinga
Why Virpax Pharmaceuticals Stock Flying Higher?
August 17, 2021
Virpax Pharmaceuticals Inc (NASDAQ: VRPX) has received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019. The drug candidate...
Via
Benzinga
Exposures
Product Safety
Virpax® Pharmaceuticals Receives FDA Response and Guidance on MMS019
August 17, 2021
From
Virpax® Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Reports 2021 Second Quarter Results and Recent Developments
August 10, 2021
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax® Pharmaceuticals Strengthens Board of Directors with the Appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board
July 30, 2021
From
Virpax Pharmaceuticals
Via
Business Wire
54 Biggest Movers From Yesterday
July 16, 2021
Gainers Sight Sciences, Inc. (NASDAQ: SGHT) shares jumped 39.6% to settle at $33.50 on Thursday as the company priced its IPO at $24 per share. Cinedigm Corp. (NASDAQ: CIDM)...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
32 Stocks Moving In Thursday's Mid-Day Session
July 15, 2021
Gainers ATA Creativity Global (NASDAQ: AACG) shares jumped 37.8% to $4.1050. Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 20.9% to $3.01. Verb Technology shares...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.